ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
561 hedge funds and large institutions have $26B invested in Alexion Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 220 increasing their positions, 204 reducing their positions, and 61 closing their positions.
Holders
561
Holders Change
+13
Holders Change %
+2.37%
% of All Funds
13.99%
Holding in Top 10
17
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-29.17%
% of All Funds
0.42%
New
84
Increased
220
Reduced
204
Closed
61
Calls
$261M
Puts
$257M
Net Calls
+$4.33M
Net Calls Change
+$22.1M
Top Buyers
| 1 |
1
BlackRock
New York
|
$2.26B |
| 2 |
2
JPMorgan Chase & Co
New York
|
$372M |
| 3 |
3
Jennison Associates
New York
|
$1.17B |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$374M |
| 5 |
PI
5
Putnam Investments
Boston,
Massachusetts
|
$115M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCA
626
Secor Capital Advisors
New York
| – | – | – | – |
|
|
TH
627
Timber Hill
Greenwich,
Connecticut
| – | – | – | – |
|
628
D.E. Shaw & Co
New York
| – | – | – | – |
|
|
WA
629
WFG Advisors
Dallas,
Texas
| $0 | 1 | – | – |
|
|
ST
630
Spot Trading
Chicago,
Illinois
| – | – | – | – |
|
|
SM
631
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|